As a special subtype, human epidermal growth factor receptor 2 (HER2)-positive breast cancer accounts for 15–20% of all breast cancer, which is characterized by aggressive behaviors and poor prognosis [2]. The gene discussed is ERBB2; the disease is breast carcinoma.